A Prospective Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma
Latest Information Update: 22 Aug 2022
At a glance
- Drugs Bendamustine (Primary) ; Cytarabine (Primary) ; Ibrutinib (Primary) ; Prednisone (Primary) ; Rituximab (Primary) ; Zanubrutinib (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 22 Aug 2022 New trial record